John Glenn sold $135k of IRMD
CHIEF FINANCIAL OFFICER at IRADIMED CORP. 2,500 shares at an average of $54.18, traded Dec 2, 2024, filed Dec 2, 2024.
Score components
- +22RoleCFO
- +11Trade size$135k at market
- +10Share of holdings soldSold 36% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-028036, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 2, 2024 | SOpen-market sale Common Stock | -2,500 | $54.18 | $135k | 4,383 | Dec 2, 2024 |
Related signals
Other insiders at IRADIMED CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $123k 1,419 shares | -7% | |
| 20Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $356k 5,000 shares | -0% | |
| 20Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $356k 5,000 shares | -0% | |
| 23Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $76k 1,102 shares | -5% | |
| 31Weak | IRMDsell IRADIMED CORP | Anthony Vuoto director | $151k 2,690 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.